| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/24/2002 | EP1223936A1 Oral formulations for anti-tumor compounds |
| 07/24/2002 | EP1223932A1 Compounds and methods |
| 07/24/2002 | EP1223929A1 Cannabimimetic indole derivatives |
| 07/24/2002 | EP1223923A1 Method for protecting normal cells from cytotoxicity of chemotherapeutic agents |
| 07/24/2002 | EP1223921A2 Tissue factor antagonists and methods of use thereof |
| 07/24/2002 | EP1223916A2 Neutral-cationic lipid for nucleic acid and drug delivery |
| 07/24/2002 | EP1223915A1 Dry powder compositions having improved dispersivity |
| 07/24/2002 | EP1119367A4 Method of using fetuin to induce apoptosis in cancer cells |
| 07/24/2002 | EP1032408B1 Galenic preparation for prevention and treatment of hepatocarcinoma |
| 07/24/2002 | EP0885230B1 Camptothecin derivatives and the use thereof as antitumor agents |
| 07/24/2002 | EP0835263B9 Somatostatin peptides |
| 07/24/2002 | EP0741716B1 Delta 12,13 -iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them |
| 07/24/2002 | EP0739210B1 Compositions for local delivery of cytostatic agents |
| 07/24/2002 | EP0684835B1 Ligand antagonists for treatment of breast cancer |
| 07/24/2002 | CN1360636A Modified human granulocyte-colony stimulating factor and process for producing same |
| 07/24/2002 | CN1360631A Methods and compositions for preventing formation of aberrant RNA during transcription of plasmid sequence |
| 07/24/2002 | CN1360628A Method for transfer of antigens to dendritic cells |
| 07/24/2002 | CN1360596A Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 07/24/2002 | CN1360595A Immunogenic peptides derived from MAGE and use thereof |
| 07/24/2002 | CN1360588A Hemisynthetic method and intermediate thereof |
| 07/24/2002 | CN1360581A Benzoylpyridazines |
| 07/24/2002 | CN1360577A Hydroxamic acid derivs. as matrix metalloprotease inhibitors |
| 07/24/2002 | CN1360572A Vitamin D3 Analogs |
| 07/24/2002 | CN1360570A Phenyl sulfamate derivs. |
| 07/24/2002 | CN1360568A Diacylhydrazine derivs. |
| 07/24/2002 | CN1360507A Conjugates and method for production thereof, and their use for transporting molecules via biological membranes |
| 07/24/2002 | CN1360503A Compositions and uses of ET 743 for treating cancer |
| 07/24/2002 | CN1360025A Autoimmune cell for treating tumor and its preparing process |
| 07/24/2002 | CN1359900A Metal protease inhibitor, preparing process thereof and pharmaceutical composition contg. same |
| 07/24/2002 | CN1359723A Chinese medicine for treating tumor and its preparing process |
| 07/24/2002 | CN1359714A Medicine for treating dermatopathy |
| 07/24/2002 | CN1359711A Anticancer oral liquid and its preparing process |
| 07/24/2002 | CN1359702A Prescription and preparing process for Chinese medicine |
| 07/24/2002 | CN1359688A Shengta rhodiola |
| 07/24/2002 | CN1359645A Health-care anticancer gingko beverage and its preparing process |
| 07/24/2002 | CN1087941C Compositions for prevention and treatment of viral-induced tumors |
| 07/23/2002 | US6423840 Forming n-acylamino compound |
| 07/23/2002 | US6423753 Controlling angiogenesis |
| 07/23/2002 | US6423744 Administering an amount of a leukotriene b4 (ltb4) antagonist, preferably a ltb4 receptor antagonistic, to a patient exhibiting adverse drug effect due to exogenous interleukin-2, to decrease the adverse effects |
| 07/23/2002 | US6423736 Administering benzimidazole compound |
| 07/23/2002 | US6423735 Administering benzimidazole compound |
| 07/23/2002 | US6423734 Administering benzimidazole compound |
| 07/23/2002 | US6423720 Pyrimidine compounds and methods for making and using the same |
| 07/23/2002 | US6423712 2,4-Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 07/23/2002 | US6423710 Cyclic AMP-specific phosphodiesterase inhibitors |
| 07/23/2002 | US6423708 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/23/2002 | US6423702 Process for the hydroxylation of an acyclic or cyclic methylene radical in the allylic position, pharmaceutical composition containing hydroxycholesterol derivatives and utilization of such compositions for the preparation of drugs |
| 07/23/2002 | US6423686 LHRH antagonist peptides |
| 07/23/2002 | US6423547 Non-covalent bioconjugates useful for diagnosis and therapy |
| 07/23/2002 | US6423539 Enhancing immunology response |
| 07/23/2002 | US6423527 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 07/23/2002 | US6423521 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/23/2002 | US6423513 Polynucleotide encoding proprotein comprising cell recognition domain binding to exterior surface of targeted cell, domain effecting translocation to cell cytosol upon proteolytic cleavage, cytotoxicity domain, endoplasmic reticulum retention |
| 07/23/2002 | US6423511 Humanized antibodies |
| 07/23/2002 | US6423507 Detecting enzyme inhibitors; obtain protease, incubate with modulator, monitor adjustment in protease activity |
| 07/23/2002 | US6423308 Treatment of Kaposi's sarcoma with IL-12 |
| 07/23/2002 | CA2369183A1 Means and methods for treatment evaluation |
| 07/23/2002 | CA2365997A1 Novel polypeptide |
| 07/23/2002 | CA2168440C Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer |
| 07/23/2002 | CA2074720C Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 07/23/2002 | CA2042503C Novel bifunctional linking compounds, conjugates and methods for their production |
| 07/18/2002 | WO2002056027A2 Regulation of neutral development by daedalos |
| 07/18/2002 | WO2002056022A2 Diagnostics, drug screening and treatment for cancer |
| 07/18/2002 | WO2002055706A2 Asip-related proteins |
| 07/18/2002 | WO2002055705A2 Proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055700A2 Human genes and gene expression products isolated from human prostate |
| 07/18/2002 | WO2002055698A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | WO2002055695A1 Human glioma antigen and process for preparing the same |
| 07/18/2002 | WO2002055693A2 Method for inhibiting the expression of a target gene |
| 07/18/2002 | WO2002055692A2 Method for inhibiting the expression of a target gene and medicament for treating a tumor disease |
| 07/18/2002 | WO2002055691A1 Gene encoding aip-1/flash promoter and use thereof |
| 07/18/2002 | WO2002055690A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/18/2002 | WO2002055688A2 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms |
| 07/18/2002 | WO2002055678A1 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissues |
| 07/18/2002 | WO2002055676A2 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 07/18/2002 | WO2002055675A1 Ancillary composition for the preparation of committed mature dendritic cells |
| 07/18/2002 | WO2002055555A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | WO2002055547A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 07/18/2002 | WO2002055542A2 Hpv-specific peptides, which block the binding of hpv to the host cell |
| 07/18/2002 | WO2002055541A2 Peptides having inhibiting activity on the production of nitric oxide |
| 07/18/2002 | WO2002055539A1 Process to concentrate insoluble proteins by vibrating membrane filtration |
| 07/18/2002 | WO2002055533A2 Methods of using imxp-888 and imxp-888 antagonists |
| 07/18/2002 | WO2002055532A2 Variant growth hormone molecules conjugated with macromolecular compounds |
| 07/18/2002 | WO2002055530A2 Transcobalamin binding conjugates useful for treating abnormal cellular proliferation |
| 07/18/2002 | WO2002055525A1 Retinoid agonists |
| 07/18/2002 | WO2002055523A1 Mikanolide derivatives, their preparation and therapeutic uses |
| 07/18/2002 | WO2002055517A2 4-(hetero)aryl substituted indolinones |
| 07/18/2002 | WO2002055515A1 Chemical derivatives and their use as anti-telomerase agent |
| 07/18/2002 | WO2002055510A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 07/18/2002 | WO2002055507A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors |
| 07/18/2002 | WO2002055502A1 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 07/18/2002 | WO2002055501A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | WO2002055498A1 Pharmaceutically active piperidine derivatives |
| 07/18/2002 | WO2002055491A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) |
| 07/18/2002 | WO2002055108A1 Targeted modification of intracellular compounds |
| 07/18/2002 | WO2002055106A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 07/18/2002 | WO2002055103A1 Tumor vaccines |
| 07/18/2002 | WO2002055100A2 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 07/18/2002 | WO2002055095A2 Use of aziridino-compounds in the treatment of immune dysfunctions |
| 07/18/2002 | WO2002055092A1 Preventives and/or remedies for digestive diseases |